Have a personal or library account? Click to login
Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy Cover

Early-time-point 18F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy

Open Access
|Feb 2025

Authors

Nezka Hribernik

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Katja Strasek

Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia

Andrej Studen

Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Experimental Particle Physics Department, Jozef Stefan Institute, Ljubljana, Slovenia

Katarina Zevnik

Department of Nuclear Medicine, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Katja Skalic

Department of Nuclear Medicine, Institute of Oncology Ljubljana, Ljubljana, Slovenia

Robert Jeraj

Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
University of Wisconsin Carbone Cancer Centre, Madison, USA
Department of Medical Physics, University of Wisconsin-Madison, Madison, USA
Experimental Particle Physics Department, Jozef Stefan Institute, Ljubljana, Slovenia

Martina Rebersek

mrebersek@onko-i.si

Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
DOI: https://doi.org/10.2478/raon-2025-0014 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 43 - 53
Submitted on: Dec 12, 2024
|
Accepted on: Jan 4, 2025
|
Published on: Feb 27, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2025 Nezka Hribernik, Katja Strasek, Andrej Studen, Katarina Zevnik, Katja Skalic, Robert Jeraj, Martina Rebersek, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.